Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 2
1958 1
1959 1
1960 2
1961 2
1962 1
1963 1
1964 6
1965 3
1966 3
1967 1
1968 2
1969 1
1970 4
1971 2
1972 3
1973 2
1974 3
1975 3
1976 6
1977 7
1978 3
1979 4
1980 4
1981 6
1982 7
1983 6
1984 1
1985 5
1986 7
1987 4
1988 6
1989 4
1990 4
1991 11
1992 2
1993 4
1994 8
1995 3
1996 9
1997 4
1998 8
1999 12
2000 3
2001 15
2002 18
2003 14
2004 14
2005 6
2006 4
2007 25
2008 24
2009 24
2010 14
2011 10
2012 13
2013 8
2014 11
2015 10
2016 21
2017 20
2018 19
2019 11
2020 19
2021 17
2022 18
2023 13
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

504 results

Results by year

Filters applied: . Clear all
Page 1
The Stanford Hall consensus statement for post-COVID-19 rehabilitation.
Barker-Davies RM, O'Sullivan O, Senaratne KPP, Baker P, Cranley M, Dharm-Datta S, Ellis H, Goodall D, Gough M, Lewis S, Norman J, Papadopoulou T, Roscoe D, Sherwood D, Turner P, Walker T, Mistlin A, Phillip R, Nicol AM, Bennett AN, Bahadur S. Barker-Davies RM, et al. Among authors: gough m. Br J Sports Med. 2020 Aug;54(16):949-959. doi: 10.1136/bjsports-2020-102596. Epub 2020 May 31. Br J Sports Med. 2020. PMID: 32475821 Free PMC article.
CUB Domain-Containing Protein 1 (CDCP1) is a rational target for the development of imaging tracers and antibody-drug conjugates for cancer detection and therapy.
Khan T, Lyons NJ, Gough M, Kwah KKX, Cuda TJ, Snell CE, Tse BW, Sokolowski KA, Pearce LA, Adams TE, Rose SE, Puttick S, Pajic M, Adams MN, He Y, Hooper JD, Kryza T. Khan T, et al. Among authors: gough m. Theranostics. 2022 Oct 3;12(16):6915-6930. doi: 10.7150/thno.78171. eCollection 2022. Theranostics. 2022. PMID: 36276654 Free PMC article.
Neoadjuvant immunoradiotherapy results in high rate of complete pathological response and clinical to pathological downstaging in locally advanced head and neck squamous cell carcinoma.
Leidner R, Crittenden M, Young K, Xiao H, Wu Y, Couey MA, Patel AA, Cheng AC, Watters AL, Bifulco C, Morris G, Rushforth L, Nemeth S, Urba WJ, Gough M, Bell RB. Leidner R, et al. Among authors: gough m. J Immunother Cancer. 2021 May;9(5):e002485. doi: 10.1136/jitc-2021-002485. J Immunother Cancer. 2021. PMID: 33963014 Free PMC article. Clinical Trial.
Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer.
J Gunderson A, Rajamanickam V, Bui C, Bernard B, Pucilowska J, Ballesteros-Merino C, Schmidt M, McCarty K, Philips M, Piening B, Dubay C, Medler T, Newell P, Hansen P, Tran E, Tang E, Bifulco C, Crittenden M, Gough M, Young KH. J Gunderson A, et al. Among authors: gough m. Oncoimmunology. 2021 Mar 17;10(1):1900635. doi: 10.1080/2162402X.2021.1900635. Oncoimmunology. 2021. PMID: 33796412 Free PMC article.
Cryptorchidism.
Gough MH. Gough MH. Br J Surg. 1989 Feb;76(2):109-12. doi: 10.1002/bjs.1800760203. Br J Surg. 1989. PMID: 2564796 Review. No abstract available.
Defining Immunogenic and Radioimmunogenic Tumors.
Medler TR, Blair TC, Crittenden MR, Gough MJ. Medler TR, et al. Among authors: gough mj. Front Oncol. 2021 Mar 19;11:667075. doi: 10.3389/fonc.2021.667075. eCollection 2021. Front Oncol. 2021. PMID: 33816320 Free PMC article. Review.
Commentary.
Gough MJ. Gough MJ. Br J Surg. 2010 Jan;97(1):36. doi: 10.1002/bjs.6934. Br J Surg. 2010. PMID: 20013924 No abstract available.
Role of the immunosuppressive microenvironment in immunotherapy.
Tormoen GW, Crittenden MR, Gough MJ. Tormoen GW, et al. Among authors: gough mj. Adv Radiat Oncol. 2018 Oct 23;3(4):520-526. doi: 10.1016/j.adro.2018.08.018. eCollection 2018 Oct-Dec. Adv Radiat Oncol. 2018. PMID: 30370351 Free PMC article. Review.
Dioxin.
Gough M. Gough M. Lancet. 1999 Jun 19;353(9170):2163-4. doi: 10.1016/S0140-6736(05)75608-7. Lancet. 1999. PMID: 10382733 No abstract available.
UGDH promotes tumor-initiating cells and a fibroinflammatory tumor microenvironment in ovarian cancer.
Harrington BS, Kamdar R, Ning F, Korrapati S, Caminear MW, Hernandez LF, Butcher D, Edmondson EF, Traficante N, Hendley J; Australian Ovarian Cancer Study; Gough M, Rogers R, Lourie R, Shetty J, Tran B, Elloumi F, Abdelmaksoud A, Nag ML, Mazan-Mamczarz K, House CD, Hooper JD, Annunziata CM. Harrington BS, et al. Among authors: gough m. J Exp Clin Cancer Res. 2023 Oct 19;42(1):270. doi: 10.1186/s13046-023-02820-z. J Exp Clin Cancer Res. 2023. PMID: 37858159 Free PMC article.
504 results